These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 31727566)

  • 21. Microbiological criteria in non-tuberculous mycobacteria pulmonary disease: a tool for diagnosis and epidemiology.
    Jankovic M; Sabol I; Zmak L; Jankovic VK; Jakopovic M; Obrovac M; Ticac B; Bulat LK; Grle SP; Marekovic I; Samarzija M; van Ingen J
    Int J Tuberc Lung Dis; 2016 Jul; 20(7):934-40. PubMed ID: 27287647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical course and significance of nontuberculous mycobacteria and its subtypes in cystic fibrosis.
    Eikani MS; Nugent M; Poursina A; Simpson P; Levy H
    BMC Infect Dis; 2018 Jul; 18(1):311. PubMed ID: 29980189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Nontuberculous mycobacteria in cystic fibrosis].
    Le Bourgeois M; Sermet-Gaudelus I; Catherinot E; Gaillard JL
    Arch Pediatr; 2005 Aug; 12 Suppl 2():S117-21. PubMed ID: 16129322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-tuberculous mycobacteria profiles and their anti-mycobacterial resistance at a major medical center in Lebanon.
    Araj GF; Baba OZ; Itani LY; Avedissian AZ; Sobh GM
    J Infect Dev Ctries; 2019 Jul; 13(7):612-618. PubMed ID: 32065818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of Non-Tuberculosis Mycobacteria by Line Probe Assay and Determination of Drug Resistance Patterns of Isolates in Iranian Patients.
    Karami-Zarandi M; Bahador A; Gizaw Feysia S; Kardan-Yamchi J; Hasan-Nejad M; Mosavari N; Feizabadi MM
    Arch Razi Inst; 2019 Dec; 74(4):375-384. PubMed ID: 31939254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria.
    van Ingen J; Boeree MJ; van Soolingen D; Mouton JW
    Drug Resist Updat; 2012 Jun; 15(3):149-61. PubMed ID: 22525524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Failure among Patients with Non-Tuberculous Mycobacterial Infections in Skin, Soft Tissue, and Musculoskeletal System in Southern Taiwan, 2012-2015.
    Hsueh JH; Fang SY; Hsieh YH; Chen LW; Lee SS
    Surg Infect (Larchmt); 2019 Sep; 20(6):492-498. PubMed ID: 31066636
    [No Abstract]   [Full Text] [Related]  

  • 28. [Non-tuberculous mycobacteriosis. What has been coming out].
    Kajiki A
    Kekkaku; 2011 Feb; 86(2):113-25. PubMed ID: 21404655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment and outcome of non-tuberculous mycobacterial pulmonary disease in a predominantly fibro-cavitary disease cohort.
    Zweijpfenning S; Kops S; Magis-Escurra C; Boeree MJ; van Ingen J; Hoefsloot W
    Respir Med; 2017 Oct; 131():220-224. PubMed ID: 28947034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-Tuberculous Mycobacteria: Classification, Diagnostics, and Therapy.
    Porvaznik I; Solovič I; Mokrý J
    Adv Exp Med Biol; 2017; 944():19-25. PubMed ID: 27826888
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NTM drug discovery: status, gaps and the way forward.
    Wu ML; Aziz DB; Dartois V; Dick T
    Drug Discov Today; 2018 Aug; 23(8):1502-1519. PubMed ID: 29635026
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical relevance of pulmonary non-tuberculous mycobacterial isolates in three reference centres in Belgium: a multicentre retrospective analysis.
    Vande Weygaerde Y; Cardinaels N; Bomans P; Chin T; Boelens J; André E; Van Braeckel E; Lorent N
    BMC Infect Dis; 2019 Dec; 19(1):1061. PubMed ID: 31847834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictive factors for a one-year improvement in nontuberculous mycobacterial pulmonary disease: An 11-year retrospective and multicenter study.
    Cadelis G; Ducrot R; Bourdin A; Rastogi N
    PLoS Negl Trop Dis; 2017 Aug; 11(8):e0005841. PubMed ID: 28787454
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preliminary Study on Drug Susceptibility Profile and Resistance Mechanisms to Macrolides of Clinical Isolates of Non-tuberculous Mycobacteria from China.
    Li F; Li GL; Pang H; Liu HC; Xiao TY; Li SJ; Luo Q; Jiang Y; Wang RB; Wan KL
    Biomed Environ Sci; 2018 Apr; 31(4):290-299. PubMed ID: 29773092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimicrobial susceptibility and MIC distribution of 41 drugs against clinical isolates from China and reference strains of nontuberculous mycobacteria.
    Li G; Pang H; Guo Q; Huang M; Tan Y; Li C; Wei J; Xia Y; Jiang Y; Zhao X; Liu H; Zhao LL; Liu Z; Xu D; Wan K
    Int J Antimicrob Agents; 2017 Mar; 49(3):364-374. PubMed ID: 28131606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetic studies in patients with nontuberculous mycobacterial lung infections.
    Magis-Escurra C; Alffenaar JW; Hoefnagels I; Dekhuijzen PN; Boeree MJ; van Ingen J; Aarnoutse RE
    Int J Antimicrob Agents; 2013 Sep; 42(3):256-61. PubMed ID: 23837923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antimycobacterial susceptibility against nontuberculous mycobacteria using brothmic NTM].
    Kawata N; Kawahara S; Tada A; Takigawa N; Shibayama T; Soda R; Takahashi K
    Kekkaku; 2006 Apr; 81(4):329-35. PubMed ID: 16715941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [IMPACT OF COEXISTING NONTUBERCULOUS MYCOBACTERIA DURING THE TREATMENT OF PULMONARY TUBERCULOSIS].
    Katsube O; Kikkawa Y; Takizawa H; Hase I; Morita H; Nomura Y; Ogawa K; Numao T
    Kekkaku; 2015 Aug; 90(8):607-12. PubMed ID: 26665516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The development of pneumothorax in an elderly woman during treatment for nontuberculous mycobacterium].
    Ando K; Ishii M; Yonenaga A; Shibasaki K; Yamaguchi Y; Urano T; Ogawa S; Akishita M
    Nihon Ronen Igakkai Zasshi; 2018; 55(1):136-142. PubMed ID: 29503357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Real-life evaluation of clinical outcomes in patients undergoing treatment for non-tuberculous mycobacteria lung disease: A ten-year cohort study.
    Aliberti S; Sotgiu G; Castellotti P; Ferrarese M; Pancini L; Pasat A; Vanoni N; Spotti M; Mazzola E; Gramegna A; Saderi L; Perno CF; van Ingen J; Codecasa LR; Blasi F
    Respir Med; 2020 Apr; 164():105899. PubMed ID: 32094101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.